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stress-induced over-expression of caveolin-1 in the cellular aging. Our
recent study revealed that angiogenic growth factors, especially vascular
endothelial growth factor (VEGF), downregulate catabolic activity and
cellular aging, and also maintain anabolic viability in chondrocytes. We
also review the underlying signal transduction pathways. Finally, we show
that newly developed antioxidant C60 is a useful as a therapuetic agent
sto reduce articular cartilage degeneration in the OA rabbit model.
Conclusions: Our studies reported here sought to demonstrate in the
OA model in vitro and in vivo that oxidative stress is closely involved in
the caritilage/chondrocyte aging and degeneration and that angiogenic
growth factors may at least in part participate in the pathogenesis of OA.
Also, we demenstrate that water-soluble C60 fullerene, a strong free-
radical scavenger, can function as a protective agent against the catabolic
stress-induced degeneration of articular cartilage.
I-20 THE APPLICATION OF PROTEOMICS IN THE STUDY OF
OSTEOARTHRITIS
D.S. Gibson. Queen’s University Belfast, Belfast, UNITED KINGDOM
Purpose: For a highly complex, multifaceted disorder such as osteoarthri-
tis, proteomic approaches have much to offer. Biomarker “ﬁngerprints”
which indicate disease outcome, networks of molecular pathology and
therapeutic targets can be ﬁltered out from background signals with
proteomic techniques.
Methods: Following closely on the heels of genomic screening, proteomic
platforms have the potential to provide additional levels of understanding
to the leading edge of osteoarthritic disease. Proteomic tools have the
signiﬁcant advantage in not precluding biomarker identity, so research
strategies can be formed in an objective, “unsupervised” fashion.
Results: This talk aims to give the unitiated an overview of the tech-
nologies currently available, highlighting their assets and pitfalls. A brief
history of ﬁndings to date from published proteomics studies of synovial
ﬂuid, cells and tissue will be reviewed from a variety of arthrides. The
importance of formulating clinically relevant questions will form a major
focus and novel strategies and sufﬁcient powering of studies will be
discussed.
Conclusions: This workshop gives the opportunity to learn of the skills
now available, giving inspiration and expanding on existing knowledge.
The content is pitched at scientists and clinicians with limited knowledge
of global proteomic technologies and strategies and an interest in apply-
ing them in the study of osteoarthritis.
I-21 COMBINED TRANSCRIPTOME AND PROTEOME
APPROACHES TO ELUCIDATE GENE EXPRESSION
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M.O. Glocker. Proteome Center Rostock, Institute of Immunology,
University of Rostock, Rostock, GERMANY
Purpose:With the availability of the human genome sequence and those
of animal models, data driven research for unravelling the molecular
grounds of Rheumatoid Arthritis (RA) and Osteoarthritis, respectively, can
be considered a realistic challenge to the scientiﬁc community.
Methods: A comprehensive research strategy is presented for studying
multifactorial polygenic (autoimmune) diseases, enabling the integration
of multiple research efforts by so called proteomics and systems biology
approaches. An integrative scientiﬁc concept is discussed of how to
elucidate molecular mechanisms of complex diseases using state-of-the-
art methodologies in functional and comparative genomics.
Results: RNA, protein, and peptide microarray proﬁles are currently
obtained in cutting edge research projects producing gene signature
read-outs rather than single DNA and/or protein markers. A continuous
interchange of data-driven and hypothesis-driven research has been
established in order to investigate the value of such “marker signatures”.
Conclusions: Currently, a comprehensive study of the RNA and pro-
tein regimes is undertaken that eventually will lead to a “holistic” view
of signalling pathways that are expected to reveal how the respective
molecules and the cells themselves interact with each other; hopefully
leading to new diagnostics and therapeutics in the future.
I-22 RHO SIGNALING PATHWAYS IN CARTILAGE DEVELOPMENT
AND OSTEOARTHRITIS
F. Beier. University of Western Ontario, London, ON, CANADA
Purpose: To compare the role of Rho GTPases in the control of the
chondrocyte phenotype in development and osteoarthritis.
Methods: Rho GTPase activity in chondrocytes was determined by
G-LISA assay. Activities of speciﬁc Rho GTPases in chondrocytes were
manipulated using pharmacological and genetic approaches. Effects of
these manipulations on chondrocyte physiology in monolayer culture,
organ culture and mice were investigated using a variety of techniques, in-
cluding real-time PCR, histological and immunohistochemical techniques,
cytoskeletal staining and proliferation assays.
Results: Our results show that RhoA through its mediators ROCK1/2
suppresses both early and late (hypertrophic) chondrocyte differentiation
during cartilage development. Similarly, Rho/ROCK mediates loss of
the chondrocyte phenotype in response to transforming growth factor
alpha (TGFalpha), a growth factor that we have shown to be upregu-
lated in osteoarthritic cartilage. Importantly, ROCK inhibition suppresses
TGFalpha-induced breakdown of collagen II and aggrecan in articular
cartilage explants. In contrast, other Rho family members, most notably
Rac1 and Cdc42, promote chondrocyte maturation at multiple stages
and through different mechanisms. Cartilage-speciﬁc deletion of the Rac1
gene in mice leads to severe chondrodysplasia, with reduced chondrocyte
proliferation, skeletal malformations (e.g. scoliosis and kyphosis) and
profound dwarﬁsm. These effects appear to be mediated, at least in part,
by altered iNOs expression and nitric oxide levels, showing a novel link
between Rho GTPase and nitroc oxide signaling.
Conclusions: Our data suggest that Rho GTPases play multiple and
speciﬁc roles in the control of both growth plate and articular chondrocyte
physiology. They may therefore present novel targets for therapeutic
interventions both for osteoarthritis and disorders of skeletal development,
such as chondrodysplasias.
I-23 EPIDEMIOLOGIC EVIDENCE FOR JOINT SHAPE AS A
CAUSE OF OA
N. Lane. University of California of Davis, Center for Healthy Aging,
Sacramento, CA, USA
Purpose: Osteoarthritis of the hip is a common cause of pain and
disability in older individuals. While the major risk factors for hip OA
are both genetic and environmental, minor variations in the proximal
femur or acetabular geometry have also been identiﬁed as potential risk
factors for hip OA. These observations support the hypothesis that subtle
variation in proximal femur/acetabular morphology may compromise the
joint biomechanically and lead to hip OA. Two recent studies will be
reviewed that utilized active shape modeling of the proximal femur to
determine what proximal femur shapes are risk factors for hip OA.
Methods: The pelvic radiographs used for these analyses were obtained
in the supine position. A baseline and follow-up radiograph was assessed
for presence and severity of radiographic hip OA with either a modiﬁed
Croft or a Kellgren and Lawrence method. The shape of the proximal
right femur was outlined using a digitized radiograph from the baseline
visit, by placing points evenly spaced points around the proximal femur.
The Active Shape Modeling Program (University of Manchester, UK) was
applied to the datasets to assess shapes in the femoral head, neck and
shaft before, during and after the development of radiographic hip OA.
Scores of shape variance, or mode scores were assigned to 10 modes of
variation in each hip, and differences in mode scores were determined.
Results: Incident hip OA study: the baseline shape analysis was sig-
niﬁcantly different between RHOA cases and controls in 3 modes (3,
5, and 9) (p< 0.001). Mode 3 (associated with the most variance of
9%) represented a subgroup with incident RHOA characterized by a
larger femoral head. Each of those three modes predicted incident RHOA
with adjusted ORs of around 1.7. A separate study reported signiﬁcant
differences in the femoral head shape between OA cases and controls
and hips with OA progression but not in the control group over time.
Conclusions: These studies and others support the hypothesis that
subtle variations in the shape of the proximal femur (either the femoral
head or femoral neck) and or the acetabulum appear to increase the risk
of incident and progressive RHOA. Research should now be directed
toward novel interventions that might be able slow the progression of hip
OA in individuals with these subtle variations in hip shape.
